We expanded drug-reacting T cells from β-lactam allergic individuals, such as patients with typically IgE-mediated hypersensitivity reactions such as urticaria or anaphylaxis as well as patients with T-cell mediated reactions such as MPE and severe cutaneous adverse reactions (SCAR). This evidence concerns the gene IGHE and urticaria.